Navigation Links
Big pharma seeks Wisconsin biotech partnerships
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Big pharma seeks Wisconsin biotech partnerships

Breaking Biology News(10 mins):Stand Up to Cancer funds high-risk/high-reward cancer research by 13 young scientists 2Stand Up to Cancer funds high-risk/high-reward cancer research by 13 young scientists 3Stand Up to Cancer funds high-risk/high-reward cancer research by 13 young scientists 4Stand Up to Cancer funds high-risk/high-reward cancer research by 13 young scientists 5Stand Up to Cancer funds high-risk/high-reward cancer research by 13 young scientists 6Mylan Schedules Third Quarter 2009 Financial Results Conference Call and Live Webcast 5483 1New Data Showed Type 2 Diabetes Patients Experienced Greater Blood Sugar Reductions when Treated with ACTOplus met 28R 29 28pioglitazone HCl and metf 5480 1New Data Showed Type 2 Diabetes Patients Experienced Greater Blood Sugar Reductions when Treated with ACTOplus met 28R 29 28pioglitazone HCl and metf 5480 2New Data Showed Type 2 Diabetes Patients Experienced Greater Blood Sugar Reductions when Treated with ACTOplus met 28R 29 28pioglitazone HCl and metf 5480 3New Data Showed Type 2 Diabetes Patients Experienced Greater Blood Sugar Reductions when Treated with ACTOplus met 28R 29 28pioglitazone HCl and metf 5480 4New Data Showed Type 2 Diabetes Patients Experienced Greater Blood Sugar Reductions when Treated with ACTOplus met 28R 29 28pioglitazone HCl and metf 5480 5New Data Showed Type 2 Diabetes Patients Experienced Greater Blood Sugar Reductions when Treated with ACTOplus met 28R 29 28pioglitazone HCl and metf 5480 6Dialysis Drawbacks Outweigh Benefits for Some Older Patients 59479 1Dialysis Drawbacks Outweigh Benefits for Some Older Patients 59479 2Dialysis Drawbacks Outweigh Benefits for Some Older Patients 59479 3